PNGAF (The Precision Peptide Co) Other Financing: $2.30 Mil (TTM As of Jan. 2026)


PNGAF The Precision Peptide Co Inc PNGAF
21 GF Score
Price $0.34
! 4 Warning Signs
View Full Analysis

What is The Precision Peptide Co Other Financing?

The Precision Peptide Co PNGAF -1.93% 21 Other Financing is $2.30 Mil as of Jan. 2026. GuruFocus rates PNGAF with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

The Precision Peptide Co's Other Financing for the three months ended in Jan. 2026 was $0.00 Mil.

The Precision Peptide Co's Other Financing for the trailing twelve months (TTM) ended in Jan. 2026 was $2.30 Mil.

The Precision Peptide Co Other Financing Historical Data

* Premium members only.

The historical data trend for The Precision Peptide Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Precision Peptide Co Other Financing Chart

The Precision Peptide Co Annual Data
Trend Oct21 Oct22 Oct23 Oct24 Oct25
Other Financing
0.00 0.02 0.14 0.00 2.07

The Precision Peptide Co Quarterly Data
Jul21 Oct21 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.53 1.56 0.21 0.00
PNGAF
21GF Score
The Precision Peptide Co Inc PNGAF
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Precision Peptide Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $2.30 Mil mean?
The Precision Peptide Co (PNGAF) has a Other Financing of $2.30 Mil as of Jan. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for The Precision Peptide Co and its competitors.
Is The Precision Peptide Co's Other Financing too high?
The Precision Peptide Co's current Other Financing is $2.30 Mil. Overall, The Precision Peptide Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's Other Financing compare to KHC and GIS?
The Precision Peptide Co's Other Financing of $2.30 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Consumer Packaged Goods company?
A good Other Financing depends on the Consumer Packaged Goods industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for The Precision Peptide Co and its competitors. The Precision Peptide Co's current Other Financing is $2.30 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current Other Financing of $2.30 Mil. The current Other Financing is $2.30 Mil. The Precision Peptide Co's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current Other Financing is $2.30 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Precision Peptide Co Business Description

Other Exchanges XU0:GermanyBPC:Canada
Address 130th Street, Suite 8035, Surrey, BC, CAN, V3W 0H7
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
21GF Score

Get the complete analysis for PNGAF

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.34
Price